FPH.NZ - Fisher & Paykel Healthcare Corporation Limited

NZSE - NZSE Delayed Price. Currency in NZD
14.80
+0.27 (+1.86%)
At close: 4:59PM NZST
Stock chart is not supported by your current browser
Previous Close14.53
Open14.56
Bid14.56 x 485800
Ask14.80 x 241000
Day's Range14.56 - 14.80
52 Week Range10.86 - 15.50
Volume615,929
Avg. Volume894,006
Market Cap8.464B
Beta1.60
PE Ratio (TTM)44.85
EPS (TTM)0.33
Earnings DateMay 21, 2018 - May 25, 2018
Forward Dividend & Yield0.25 (1.68%)
Ex-Dividend Date2018-06-21
1y Target Est12.35
  • Thomson Reuters StreetEventsyesterday

    Edited Transcript of FPH.NZ earnings conference call or presentation 27-May-18 10:00pm GMT

    Preliminary 2018 Fisher & Paykel Healthcare Corporation Ltd Earnings Call

  • Top Growth Stocks To Buy Today
    Simply Wall St.27 days ago

    Top Growth Stocks To Buy Today

    Robust, high-growth companies such as NZX are appealing to investors for many reasons. They bring about a strong upside to your portfolio, and less downside risk as opposed to financiallyRead More...

  • June Fundamental Stock Pick: Fisher & Paykel Healthcare Corporation Limited (NZE:FPH)
    Simply Wall St.last month

    June Fundamental Stock Pick: Fisher & Paykel Healthcare Corporation Limited (NZE:FPH)

    Building up an investment case requires looking at a stock holistically. Today I’ve chosen to put the spotlight on Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) due to its excellentRead More...

  • Is Fisher & Paykel Healthcare Corporation Limited (NZE:FPH) As Strong As Its Balance Sheet Indicates?
    Simply Wall St.4 months ago

    Is Fisher & Paykel Healthcare Corporation Limited (NZE:FPH) As Strong As Its Balance Sheet Indicates?

    Small-cap and large-cap companies receive a lot of attention from investors, but mid-cap stocks like Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH), with a market cap of NZ$7.57B, are oftenRead More...

  • Does Fisher & Paykel Healthcare Corporation Limited’s (NZE:FPH) PE Ratio Signal A Selling Opportunity?
    Simply Wall St.4 months ago

    Does Fisher & Paykel Healthcare Corporation Limited’s (NZE:FPH) PE Ratio Signal A Selling Opportunity?

    Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) is trading with a trailing P/E of 42.7x, which is higher than the industry average of 33.3x. While this makes FPH appear likeRead More...

  • Should You Buy Fisher & Paykel Healthcare Corporation Limited (NZE:FPH)?
    Simply Wall St.5 months ago

    Should You Buy Fisher & Paykel Healthcare Corporation Limited (NZE:FPH)?

    Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH), a medical equipment company based in New Zealand, saw significant share price volatility over the past couple of months on the NZSE, risingRead More...

  • Does Fisher & Paykel Healthcare Corporation Limited (NZE:FPH) Have A Place In Your Dividend Portfolio?
    Simply Wall St.5 months ago

    Does Fisher & Paykel Healthcare Corporation Limited (NZE:FPH) Have A Place In Your Dividend Portfolio?

    Dividends play a key role in compounding returns over time and can form a large part of our portfolio return. Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) has returned toRead More...

  • Fisher & Paykel Healthcare Corporation Limited (NZE:FPH) Delivered A Better ROE Than The Industry, Here’s Why
    Simply Wall St.6 months ago

    Fisher & Paykel Healthcare Corporation Limited (NZE:FPH) Delivered A Better ROE Than The Industry, Here’s Why

    Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) delivered an ROE of 26.97% over the past 12 months, which is an impressive feat relative to its industry average of 12.29% duringRead More...

  • Top High Growth Stocks This Week
    Simply Wall St.7 months ago

    Top High Growth Stocks This Week

    Companies such as Fisher & Paykel Healthcare and Gentrack Group have a significantly positive future outlook on the basis of their profitability and returns. Investors seeking to enhance their portfolioRead More...

  • Reuters7 months ago

    NZ's Fisher & Paykel sues Resmed in Australia over patent dispute

    New Zealand's Fisher & Paykel Healthcare filed a lawsuit in Australia on Tuesday against Resmed Inc alleging the medical device manufacturer's respiratory treatment products violate four Fisher & Paykel patents. Fisher & Paykel said it was seeking a range of legal remedies from the lawsuit, including banning the manufacture and sale of such Resmed products in Australia. Fisher & Paykel and California-based Resmed are engaged in patent disputes in several countries over medical devices used to treat respiratory conditions.

  • Thomson Reuters StreetEvents8 months ago

    Edited Transcript of FPH.NZ earnings conference call or presentation 20-Nov-17 9:00pm GMT

    Interim 2018 Fisher & Paykel Healthcare Corporation Ltd Earnings Call

  • Reuters8 months ago

    Fisher & Paykel says UK court rules rival Resmed's patent is invalid

    New Zealand's Fisher & Paykel Healthcare (FPH.NZ) said on Monday that it could continue to sell its sleep apnea masks in Britain as a UK court had ruled that rival Resmed Inc's (RMD.N) patent was invalid. Fisher & Paykel filed the case against California-based Resmed in Britain's High Court in 2016, and has similar legal proceedings underway in Germany, after Resmed had said the New Zealand company's masks violated Resmed patents. "This result confirms that UK patients can continue to purchase and enjoy the benefits of our high-performance masks," Fisher & Paykel said in a statement in which it announced the UK court ruling.

  • Reuters8 months ago

    Fisher & Paykel says UK court rules rival Resmed's patent is invalid

    New Zealand's Fisher & Paykel Healthcare said on Monday that it could continue to sell its sleep apnea masks in Britain as a UK court had ruled that rival Resmed Inc's patent was invalid. Fisher & Paykel filed the case against California-based Resmed in Britain's High Court in 2016, and has similar legal proceedings underway in Germany, after Resmed had said the New Zealand company's masks violated Resmed patents.

  • Vista Group International And Other Top Stocks
    Simply Wall St.8 months ago

    Vista Group International And Other Top Stocks

    Fast-growing stocks may be appealing for some investors, whereas robust dividend-generating stocks may be more suitable for others. There are many different factors to deliberate on when deciding which investmentRead More...

  • Best NZSE Growth Companies
    Simply Wall St.8 months ago

    Best NZSE Growth Companies

    Looking to add potential meaningful upside to your portfolio, but unsure where to start? Stocks such as AFT Pharmaceuticals and Freightways are considered to be high growth in terms ofRead More...

  • Reuters10 months ago

    German court suspends Resmed's complaint against NZ's Fisher & Paykel

    A German court has suspended health appliance firm ResMed Inc's intellectual property proceedings against New Zealand's Fisher & Paykel Healthcare Corp, according to a statement from Fisher & Paykel. The court proceedings were suspended while both firms waited for the outcome of a European Patent Office decision over Resmed's patents, Fisher & Paykel said in a filing on Friday with New Zealand's stock exchange.